Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
432 studies found for:    Open Studies | "Schizophrenia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Schizophrenia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Trial of DMXB-A in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: 3-2,4 dimethoxybenzylidene 75 or 150 mg bid;   Drug: Placebo
2 Not yet recruiting The Optimal Treatment for Treatment-resistant Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Risperidone with Clozapine;   Drug: Aripiprazole with Clozapine;   Drug: sodium valproate with Clozapine;   Device: modified electroconvulsive therapy(MECT) with Clozapine;   Device: Magnetic seizure therapy(MST) with Clozapine
3 Not yet recruiting Evaluation Study of New Compounds With Potential Use in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: URB597;   Drug: intranasal Insulin;   Drug: Cannabidiol CR
4 Not yet recruiting An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: SEP-363856
5 Recruiting Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
Condition: Schizophrenia
Intervention: Other: insight variation measure
6 Recruiting A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo - Cap
7 Recruiting Schizophrenia TreAtment With electRic Transcranial Stimulation
Condition: Schizophrenia
Intervention: Device: Transcranial Direct Current Stimulation
8 Not yet recruiting A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia
Condition: Schizophrenia
Interventions: Dietary Supplement: sulforaphane;   Other: placebo
9 Recruiting Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive
Condition: Schizophrenia
Interventions: Other: Gluten Free Flour;   Other: Wheat Flour
10 Not yet recruiting Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.
Condition: Schizophrenia
Intervention: Device: Repetitive Transcranial Magnetic Stimulation
11 Recruiting A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ASP4345;   Drug: Matching Placebo
12 Recruiting Aerobic Exercise for Cognition in Schizophrenia
Condition: Schizophrenia
Interventions: Behavioral: Aerobic Exercise;   Behavioral: Balance and Stretching
13 Recruiting Motivation and Executive Control in Schizophrenia
Condition: Schizophrenia
Intervention: Other: realization of computerized exercises
14 Recruiting Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Condition: Chronic Schizophrenia
Interventions: Drug: Curcumin;   Drug: placebo
15 Recruiting Tryptophan MRI in People With Schizophrenia and Healthy Controls
Condition: Schizophrenia
Interventions: Drug: Tryptophan;   Drug: Placebo
16 Recruiting Effects of Eszopiclone on Sleep and Memory in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: eszopiclone;   Drug: placebo
17 Recruiting Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AVP-786;   Drug: Placebo
18 Recruiting Deep Brain Stimulation in Treatment Resistant Schizophrenia
Condition: Refractory Schizophrenia
Interventions: Procedure: Deep Brain Stimulation;   Device: DBS pulse generating device Kinetra, Medtronic
19 Recruiting A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
Condition: Schizophrenia
Intervention: Drug: Paliperidone palmitate 3 month formulation (PP3M)
20 Recruiting Carnosine and Cognitive Training in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: L-Carnosine;   Drug: Placebo;   Behavioral: Cognitive Training

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.